====== ML-792 0.2μM R08 exp505 ====== ==== Mechanism of Action ==== Inhibits SUMO-activating enzyme (SAE) * **Class / Subclass 1:** Proteostasis / SUMOylation Inhibitor ==== Technical Notes ==== * **PubChem Name:** %%[(1R,2S,4R)-4-[[5-[1-[(3-Bromophenyl)methyl]pyrazole-3-carbonyl]pyrimidin-4-yl]amino]-2-hydroxycyclopentyl]methyl sulfamate%% * **Synonyms:** N/A * **CAS #:** 1644342-14-2 * **PubChem CID:** [[https://pubchem.ncbi.nlm.nih.gov/compound/86566743|86566743]] * **IUPAC:** %%[(1R,2S,4R)-4-[[5-[1-[(3-bromophenyl)methyl]pyrazole-3-carbonyl]pyrimidin-4-yl]amino]-2-hydroxycyclopentyl]methyl sulfamate%% * **INCHI Name:** InChI=1S/C21H23BrN6O5S/c22-15-3-1-2-13(6-15)10-28-5-4-18(27-28)20(30)17-9-24-12-25-21(17)26-16-7-14(19(29)8-16)11-33-34(23,31)32/h1-6,9,12,14,16,19,29H,7-8,10-11H2,(H2,23,31,32)(H,24,25,26)/t14-,16-,19+/m1/s1 * **INCHI Key:** PZCKLTWSXFDLLP-OGWOLHLISA-N * **Molecular Weight:** 551.4 * **Canonical SMILES:** C1C(CC(C1COS(=O)(=O)N)O)NC2=NC=NC=C2C(=O)C3=NN(C=C3)CC4=CC(=CC=C4)Br * **Isomeric SMILES:** C1[C@H](C[C@@H]([C@H]1COS(=O)(=O)N)O)NC2=NC=NC=C2C(=O)C3=NN(C=C3)CC4=CC(=CC=C4)Br * **Molecular Formula:** C21H23BrN6O5S {{:chemogenomics:structures:chem-0310.svg?nolink}} * **Supplier Name:** MedKoo Biosciences * **Catalog #:** 407886 * **Lot #:** N/A * **HRMS (ESI-TOF) m/z:** (M+H)+ Calcd for C21H23BrN6O5S 551.07068; found 551.07542 * **Platform ID:** ML792 * **Min:** 4.4131; **Max:** 87.1935 {{:chemogenomics:dose_response:dr_557.png?nolink&500 |}} \\ \\ \\ \\ |< 300px 100px 200px >| ^ IC ^ Concentration (µM) ^ | IC10 |0.0014 | | IC20 |0.0085 | | IC30 |0.0286 | | IC40 |0.0774 | | IC50 |0.1928 | | IC60 |0.4805 | | IC70 |1.2990 | | IC80 |4.3720 | | IC90 |27.1400 | \\ ==== Screen Summary ==== * **Round**: 08 * **Dose**: 200nM * **Days of incubation**: 8 * **Doublings**: 2.5 * **Numbers of reads**: 16377589 ==== Screen Results ==== ^Sensitive/Resistant hits (FDR<0.05)^CRANKS^Score Plot^Top 30 Genes^Screen Similarity^Top 30 Sensitive GO terms^Top 30 Resistant GO terms^ |9/77|[[https://files.tyerslab.com/files/public/chemogenomics/cranks/ML-792_0.2uM_Round-8_exp505.txt|Scores]]|||||| {{:chemogenomics:cranks_plots:exp505.png?nolink}} ^Gene^CRANKS Score^FDR^ |[[:human_genes:N:NFATC2IP|NFATC2IP]]|-3.95|<0.01| |[[:human_genes:U:UBE2K|UBE2K]]|-3.07|<0.01| |[[:human_genes:X:XIAP|XIAP]]|-3.03|<0.01| |[[:human_genes:A:ABCG2|ABCG2]]|-2.94|<0.01| |[[:human_genes:U:UBE2D3|UBE2D3]]|-2.91|<0.01| |[[:human_genes:B:BCL2|BCL2]]|-2.81|<0.01| |[[:human_genes:S:SEC24C|SEC24C]]|-2.79|<0.01| |[[:human_genes:R:RMI2|RMI2]]|-2.59|0.03| |[[:human_genes:S:SMC5|SMC5]]|-2.58|0.06| |[[:human_genes:U:UBE2D2|UBE2D2]]|-2.55|0.03| |[[:human_genes:S:SMC2|SMC2]]|-2.51|0.26| |[[:human_genes:G:GPBP1|GPBP1]]|-2.38|0.07| |[[:human_genes:R:RMI1|RMI1]]|-2.36|0.07| |[[:human_genes:S:SH3KBP1|SH3KBP1]]|-2.36|0.07| |[[:human_genes:C:CCM2|CCM2]]|-2.35|0.07| |[[:human_genes:N:NCAPG2|NCAPG2]]|-2.29|0.13| |[[:human_genes:F:FAM13B|FAM13B]]|-2.27|0.10| |[[:human_genes:A:AP2A1|AP2A1]]|-2.26|0.10| |[[:human_genes:E:ERCC6L|ERCC6L]]|-2.24|0.17| |[[:human_genes:S:SBNO1|SBNO1]]|-2.22|0.31| |[[:human_genes:K:KCMF1|KCMF1]]|-2.22|0.11| |[[:human_genes:C:CHMP7|CHMP7]]|-2.21|0.11| |[[:human_genes:H:HOXC5|HOXC5]]|-2.21|0.11| |[[:human_genes:C:CDCA5|CDCA5]]|-2.21|0.18| |[[:human_genes:N:NHLRC2|NHLRC2]]|-2.20|0.18| |[[:human_genes:R:RNF138|RNF138]]|-2.17|0.13| |[[:human_genes:O:OPTN|OPTN]]|-2.16|0.13| |[[:human_genes:E:ERCC6|ERCC6]]|-2.16|0.19| |[[:human_genes:T:TRAIP|TRAIP]]|-2.15|0.41| |[[:human_genes:M:MCM2|MCM2]]|-2.14|0.41| |[[:human_genes:S:SUMO1|SUMO1]]|2.92|0.01| |[[:human_genes:D:DPH1|DPH1]]|2.92|<0.01| |[[:human_genes:Z:ZBTB17|ZBTB17]]|2.93|<0.01| |[[:human_genes:Z:ZNF592|ZNF592]]|2.95|<0.01| |[[:human_genes:A:ACSL4|ACSL4]]|2.99|<0.01| |[[:human_genes:A:AHCYL1|AHCYL1]]|3.13|0.00| |[[:human_genes:P:PCGF1|PCGF1]]|3.13|0.00| |[[:human_genes:Y:YLPM1|YLPM1]]|3.13|<0.01| |[[:human_genes:B:BAK1|BAK1]]|3.22|0.00| |[[:human_genes:A:ADIPOR1|ADIPOR1]]|3.29|0.00| |[[:human_genes:D:DRG1|DRG1]]|3.32|0.00| |[[:human_genes:C:CCNL1|CCNL1]]|3.33|0.00| |[[:human_genes:R:RHOH|RHOH]]|3.33|0.00| |[[:human_genes:C:CCDC82|CCDC82]]|3.34|0.00| |[[:human_genes:H:HEATR3|HEATR3]]|3.36|0.00| |[[:human_genes:Z:ZC3H15|ZC3H15]]|3.51|0.00| |[[:human_genes:R:RPL11|RPL11]]|3.51|<0.01| |[[:human_genes:O:ODC1|ODC1]]|3.55|0.00| |[[:human_genes:F:FAM60A|FAM60A]]|3.59|0.00| |[[:human_genes:K:KIAA0020|KIAA0020]]|3.61|0.00| |[[:human_genes:C:CDK6|CDK6]]|3.79|0.00| |[[:human_genes:B:BRMS1|BRMS1]]|3.89|0.00| |[[:human_genes:E:EIF3H|EIF3H]]|3.99|0.00| |[[:human_genes:F:FAM111A|FAM111A]]|4.08|0.00| |[[:human_genes:S:SUMO2|SUMO2]]|4.11|0.00| |[[:human_genes:B:BRD1|BRD1]]|4.18|0.00| |[[:human_genes:S:SLC4A7|SLC4A7]]|4.25|0.00| |[[:human_genes:R:RPS25|RPS25]]|4.34|0.00| |[[:human_genes:E:EIF4A1|EIF4A1]]|4.41|0.00| |[[:human_genes:B:BEND3|BEND3]]|6.42|0.00| ^Screen^Correlation^Plot^ |[[:results:exp444|THZ531 0.225μM R08 exp444]]|0.102|| |[[:results:exp21|MLN-4924 0.2μM R00 exp21]]|0.096|| |[[:results:exp412|THZ531 0.11 to 0.125 to 0.35μM on day4 then day6 R07 exp412]]|0.094|| |[[:results:exp413|THZ531 0.11 to 0.175μM on day4 R07 exp413]]|0.076|| |[[:results:exp524|Staurosporine 0.02μM R08 exp524]]|0.071|| |[[:results:exp512|Olaparib 4μM R08 exp512]]|0.061|| |[[:results:exp134|MS023 2μM R03 exp134]]|0.057|| |[[:results:exp526|Sulforaphane 9μM R08 exp526 no dilution day6]]|0.056|| |[[:results:exp102|Nifuroxazide 5μM R03 exp102]]|0.056|| |[[:results:exp135|MS023 7μM R03 exp135]]|0.056|| |[[:results:exp520|Rucaparib 6.5μM R08 exp520]]|0.052|| |[[:results:exp234|Ethanol 0.01 R05 exp234]]|0.095|| |[[:results:exp211|AICAR 240μM R05 exp211]]|0.07|| |[[:results:exp116|AICAR 240μM R03 exp116]]|0.068|| |[[:results:exp485|GSK626616 14μM R08 exp485]]|0.066|| |[[:results:exp497|Lead acetate 2000μM R08 exp497]]|0.062|| |[[:results:exp468|CB-5083 0.4μM R08 exp468]]|0.06|| |[[:results:exp6|Bortezomib 0.005μM R00 exp6]]|0.06|| |[[:results:exp440|Aphidicolin 0.4μM R08 exp440]]|0.056|| |[[:results:exp374|Latrunculin-B 10μM R07 exp374]]|0.056|| |[[:results:exp214|2-Deoxy-D-glucose 800μM R05 exp214]]|0.054|| |[[:results:exp500|LY2090314 0.003μM R08 exp500 no dilution day6]]|0.052|| {{:chemogenomics:comparison_plots:exp444_vs_exp505.png?nolink |}} {{:chemogenomics:comparison_plots:exp21_vs_exp505.png?nolink |}} {{:chemogenomics:comparison_plots:exp412_vs_exp505.png?nolink |}} {{:chemogenomics:comparison_plots:exp413_vs_exp505.png?nolink |}} {{:chemogenomics:comparison_plots:exp505_vs_exp524.png?nolink |}} {{:chemogenomics:comparison_plots:exp505_vs_exp512.png?nolink |}} {{:chemogenomics:comparison_plots:exp134_vs_exp505.png?nolink |}} {{:chemogenomics:comparison_plots:exp505_vs_exp526.png?nolink |}} {{:chemogenomics:comparison_plots:exp102_vs_exp505.png?nolink |}} {{:chemogenomics:comparison_plots:exp135_vs_exp505.png?nolink |}} {{:chemogenomics:comparison_plots:exp505_vs_exp520.png?nolink |}} {{:chemogenomics:comparison_plots:exp234_vs_exp505.png?nolink |}} {{:chemogenomics:comparison_plots:exp211_vs_exp505.png?nolink |}} {{:chemogenomics:comparison_plots:exp116_vs_exp505.png?nolink |}} {{:chemogenomics:comparison_plots:exp485_vs_exp505.png?nolink |}} {{:chemogenomics:comparison_plots:exp497_vs_exp505.png?nolink |}} {{:chemogenomics:comparison_plots:exp468_vs_exp505.png?nolink |}} {{:chemogenomics:comparison_plots:exp505_vs_exp6.png?nolink |}} {{:chemogenomics:comparison_plots:exp440_vs_exp505.png?nolink |}} {{:chemogenomics:comparison_plots:exp374_vs_exp505.png?nolink |}} {{:chemogenomics:comparison_plots:exp214_vs_exp505.png?nolink |}} {{:chemogenomics:comparison_plots:exp500_vs_exp505.png?nolink |}} ^GO Term^Fold Change^Genes^ |RecQ family helicase-topoisomerase III complex|380.90|RMI2,RMI1| |resolution of recombination intermediates|228.54|RMI2,RMI1| |positive regulation of chromosome segregation|65.92|SMC5,SMC2,NCAPG2| |chromosome condensation|57.13|SMC5,SMC2,NCAPG2,CDCA5| |ubiquitin conjugating enzyme activity|53.56|UBE2K,UBE2D3,UBE2D2| |double-strand break repair|17.06|RMI2,SMC5,RMI1,CDCA5,RNF138,ERCC6| |protein polyubiquitination|14.00|UBE2K,XIAP,UBE2D3,BCL2,UBE2D2| |ubiquitin protein ligase activity|11.76|UBE2K,XIAP,UBE2D3,UBE2D2,KCMF1,RNF138,TRAIP| |ubiquitin-like protein ligase activity|11.17|UBE2K,XIAP,UBE2D3,UBE2D2,KCMF1,RNF138,TRAIP| |DNA repair|9.75|UBE2D3,RMI2,SMC5,RMI1,CDCA5,RNF138,ERCC6,TRAIP| |ubiquitin-protein transferase activity|9.19|UBE2K,XIAP,UBE2D3,UBE2D2,KCMF1,RNF138,TRAIP| |ubiquitin-like protein transferase activity|8.62|UBE2K,XIAP,UBE2D3,UBE2D2,KCMF1,RNF138,TRAIP| |aminoacyltransferase activity|8.33|UBE2K,XIAP,UBE2D3,UBE2D2,KCMF1,RNF138,TRAIP| |DNA damage response|8.02|XIAP,UBE2D3,BCL2,RMI2,SMC5,RMI1,CDCA5,RNF138,ERCC6,TRAIP| |protein modification by small protein conjugation|7.64|NFATC2IP,UBE2K,XIAP,UBE2D3,BCL2,SMC5,UBE2D2,RNF138,TRAIP| |protein modification by small protein conjugation or removal|6.72|NFATC2IP,UBE2K,XIAP,UBE2D3,BCL2,SMC5,UBE2D2,RNF138,TRAIP| |regulation of cell cycle process|6.60|BCL2,RMI2,SMC5,SMC2,NCAPG2,CHMP7,CDCA5,ERCC6| |DNA metabolic process|6.40|UBE2D3,RMI2,SMC5,RMI1,CDCA5,RNF138,ERCC6,TRAIP| |post-translational protein modification|5.80|NFATC2IP,UBE2K,XIAP,UBE2D3,BCL2,SMC5,UBE2D2,RNF138,TRAIP| ^GO Term^Fold Change^Genes^ |cytoplasmic translation|29.85|EIF4A1,RPS25,EIF3H,RPL11,ZC3H15,DRG1|